Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode from the series “Key Decisions in HIV Care,” Daria Podlekareva, MD, PhD, and Mark S. Sulkowski, MD, discuss important considerations for ART use in patients with coinfections, including:
Centre of Excellence for Health, Immunity and Infections (CHIP)
Rigshospitalet, University of Copenhagen
Department of Respiratory Medicine
Bispebjerg Hospital, University of Copenhagen
Professor of Medicine
Medical Director, Viral Hepatitis Center
Chief, Infectious Disease
Johns Hopkins Bayview Medical Center
Johns Hopkins University School of Medicine
This program has been made available online.
Clinical Care Options (CCO) expert audio: Drs. Cristina Mussini and William Short discuss key data and recommendations for managing ART in the setting of opportunistic infections
Slides from CCO: Discussion of key data and recommendations for managing ART in the setting of opportunistic infections
Dr Milosz Parczewski, discusses the latest data on LA PrEP, HCV treatment in PWH, and treatments for MDR TB presented at CROI 2022 and their relevance to the CEE, from Clinical Care Options (CCO).